Bloomberg Technology published this video item, entitled “23andMe CEO on Trading Debut, GSK Deal, Branson SPAC” – below is their description.
Jun.17 — 23andMe Inc. CEO Anne Wojcicki discusses the DNA-testing company’s NASDAQ trading debut, a collaboration on drug development with GlaxoSmithKline Plc, and the choice to go public through a merger with VG Acquisition Corp., a special-purpose acquisition company founded by billionaire Richard Branson. She speaks with Bloomberg’s Emily Chang on “Bloomberg Markets: The Close.”Bloomberg Technology YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.